MediFood
MediFood is a Swiss-Hungarian medical nutrition company that develops and sells condition-specific oral nutritional supplements under the MediDrink brand for patients with disease-related malnutrition across oncology, pulmonology, gastroenterology, elderly care, and surgical indications, distributed through healthcare professionals and 16 international partners plus UK and South Africa subsidiaries.
- Company typePrivate
- Founded2008
- HeadquartersFribourg, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MediFood does
MediFood is a Swiss-headquartered, Hungary-anchored medical nutrition company that develops and commercializes condition-specific oral nutritional supplements (ONS) under the MediDrink brand for patients affected by disease-related malnutrition. The company's core technology is a portfolio of Foods for Special Medical Purposes (FSMP) formulations, each tailored to the metabolic demands of a specific clinical condition — oncology (MediDrink Neo), COPD/pulmonary disease (MediDrink Pulmo), cystic fibrosis (MediDrink CF), inflammatory bowel disease (MediDrink Gastro), elderly malnutrition (MediDrink Platinum), surgical/perioperative use (MediDrink PeriOp, OpLoad), diabetes (MediDrink RC), general malnutrition (MediDrink Plus), and pediatrics (MediDrink Kids). Products are 200ml liquid shots delivering 2.0 kcal/ml high energy density in low volume, developed in-house at the Szeged R&D Centre and produced under contract by Sole-Mizo Zrt. (Bonafarm Holding) at the Csorna manufacturing site in Hungary.
The business model is B2B2C prescription-driven: MediFood sells through healthcare professionals (dietitians, GPs, specialists) who prescribe or recommend products, and through a network of 16 international distribution partners covering European, Asian, African and Middle Eastern markets, supplemented by wholly-owned subsidiaries in the UK and South Africa (established 2023) and a German partner relationship under the LaVieCal brand. Revenue mechanics are product sales of prescription-grade clinical nutrition, with selective licensing of the formulation portfolio to partners in markets such as Greater China and Sweden. Pricing is not publicly disclosed; in some markets (e.g., Hungary for MediDrink Plus) products are reimbursed under national health insurance. Founded in 2008, the company remains privately held by its two co-founders with no disclosed institutional equity investment; growth has been partially funded through Hungarian government GINOP grants totaling ~238.8M HUF.
MediFood firmographics
Firmographics- Name
- MediFood
- Legal name
- Medifood Hungary Innovation Kft.
- Website
- https://medifoodinternational.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MediFood is a Swiss-Hungarian medical nutrition company that develops and sells condition-specific oral nutritional supplements under the MediDrink brand for patients with disease-related malnutrition across oncology, pulmonology, gastroenterology, elderly care, and surgical indications, distributed through healthcare professionals and 16 international partners plus UK and South Africa subsidiaries.
- Ownership category
- akta.pro rank
MediFood industry classification
Industry- Product category
- Clinical Nutrition (Medical Foods / Foods for Special Medical Purposes)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Medical Nutrition & Meal Replacement (RTD, Bars, Powders) (CRADAGAN)
- akta.pro secondary industry
- Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements) (AFAFAFAJ)
Keywords
Where MediFood is headquartered
LocationHeadquarters
- HQ city
- Fribourg
- HQ country
- Switzerland
- HQ region
- Europe
Offices4 records
Markets served
MediFood business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others
Revenue model
- MediDrink Product Sales: Sale of condition-specific clinical nutrition products (Foods for Special Medical Purposes) under the MediDrink brand. Products are distributed through healthcare professionals and pharmacy channels. International sales are conducted via export distribution partner agreements across multiple countries. The LaVieCal brand is used in Germany.
- Licensing and Partnership: MediFood seeks distribution partners worldwide for licensing of its innovative product portfolio. Strategic partnerships include co-development and distribution agreements with companies in China, Sweden, and other regions.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
MediFood product offering
Product offeringCore offering
MediFood develops, manufactures, and distributes condition-specific oral nutritional supplements (Foods for Special Medical Purposes, FSMP) under the MediDrink brand for patients with disease-related malnutrition. The portfolio covers 9+ therapeutic areas including oncology, COPD, cystic fibrosis, inflammatory bowel disease, elderly malnutrition, surgical/perioperative care, diabetes, and pediatric indications, with each formulation tailored in macronutrient and micronutrient profile to the specific disease state. Products are 200ml ready-to-use liquid supplements developed at the company's R&D Centre in Szeged, Hungary, and manufactured under contract in Csorna, Hungary, then sold to healthcare professionals and via 16 international distribution and licensing partners across Europe, Asia, the Middle East, and Africa (and under the LaVieCal brand in Germany).
Product overview
MediFood is a medical nutrition company offering condition-specific clinical nutrition products under the MediDrink brand. The product portfolio includes Foods for Special Medical Purposes (FSMP) designed for disease-related malnutrition across multiple therapeutic areas: MediDrink Plus (general malnutrition), MediDrink Neo (oncology), MediDrink Pulmo (COPD), MediDrink CF (cystic fibrosis), MediDrink Gastro (gastroenterology), MediDrink Platinum (elderly), MediDrink PeriOp/OpLoad (surgical), MediDrink RC (diabetes), and MediDrink Kids (pediatric). The condition-specific approach means each product addresses the unique nutritional needs of patients with specific diseases, based on scientific research and clinical studies.
Differentiator
Problem solved
Functional benefit
Brands
- MediDrink: Main product brand for condition-specific clinical nutritional supplements including MediDrink Plus, Gastro, Neo, Pulmo, CF, Platinum, OpLoad, PeriOp, Extra, Kids, RC, Renal, and Hepa variants
- LaVieCal
Products and services
- MediDrink Plus Condition-specific clinical nutrition product for general disease-related malnutrition dietary management. MediFood's first product, developed 2009-2011 and launched in Hungary with European FSMP notification and health insurance reimbursement.
- MediDrink Platinum Age-specific clinical nutrition (2.0 kcal/ml energy density) for disease-related malnutrition dietary management in elderly patients, also suitable for diabetic elderly patients. Lactose- and gluten-free, with high protein for muscle mass, omega-3 fatty acids, taurine, lutein, and zeaxanthin for cognitive and macular health. Available in chocolate, strawberry, coffee, and vanilla flavors.
- MediDrink Pulmo Condition-specific clinical nutrition for COPD (chronic obstructive pulmonary disease) patients. Low carbohydrate content reduces respiratory stress; high omega-3 fatty acids address pulmonary inflammation.
- MediDrink Neo Condition-specific clinical nutrition designed for oncology/cancer patients. Low carbohydrate content paired with increased vitamins and minerals, intended to have an indirect beneficial effect on tumor cell proliferation through nutritional modulation.
- MediDrink Extra Value-added general malnutrition oral nutritional supplement introduced to complement the condition-specific MediDrink portfolio.
- MediDrink PeriOp Surgery line clinical nutrition product for perioperative nutritional support.
- MediDrink OpLoad Pre-operative clinical nutrition product for surgical preparation.
- MediDrink CF Condition-specific clinical nutrition developed for cystic fibrosis patients.
- MediDrink Gastro Condition-specific clinical nutrition for gastroenterology patients, including Crohn's disease and ulcerative colitis. Formulated to address malabsorption and specific nutritional deficiencies caused by GI inflammation and treatment side effects.
- MediDrink RC Condition-specific clinical nutrition developed for the nutritional needs of diabetic patients (reduced glucose tolerance).
- MediDrink Kids Condition-specific clinical nutrition designed to meet nutritional needs in children and support their recovery from acute and chronic conditions.
- LaVieCal (MediDrink German market brand) Brand under which the MediDrink condition-specific clinical nutrition product portfolio is sold in the German market through distribution partner Midas Healthcare.
Quantifiable outcome
- Malnutrition prevalence in hospitalized patients aged ≥70 years reaches 43%, with 16.7% severely malnourished — highlighting the significant unmet need MediFood addresses.
- +2 more outcomes
Companies that use MediFood
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
MediFood technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
MediFood partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- MediFood UK Ltd.coreMediFood subsidiary established in 2023 for direct market operations in the United Kingdom.
- MediFood South Africa Ltd.coreMediFood subsidiary established in 2023 for direct market operations in South Africa.
- NM Pharma (Malta)minorProduct launch in Malta in 2022 through NM Pharma.
- ZAS Corporations (Bangladesh)minorProduct launch in Bangladesh in 2022 through ZAS Corporations.
- ILMA Farma (Albania)minorProduct launch in Albania in 2022 through ILMA Farma.
- Midas Healthcare (Germany) — LaVieCal BrandminorEntered the German market in 2023 through Midas Healthcare, distributing MediDrink products under the LaVieCal brand name.
- Naman Ltd. (Vietnam)minorEntered the Vietnamese market in 2021 with local partner Naman Ltd. for distribution of MediDrink products.
- MedLine (Georgia)minorMediDrink products launched in Georgia in 2020 through local distribution partner MedLine.
- Pelmy Plus Medica (Greece)minorMediDrink products launched in Greece in 2020 through Pelmy Plus Medica.
- Torus Pharma (Romania)minorPartnership for entering the Romanian FSMP market in 2019, distributing MediDrink condition-specific clinical nutrition products.
- Jilin MaiFu Nutrition Technology Co., Ltd. (China)coreLaunching MediDrink in China in 2019 with strategic partner Jilin MaiFu Nutrition Technology Co. for distribution in the Chinese market.
- Jilin MaiFu Nutrition Technology Co., Ltd.coreStrategic partnership agreement signed in 2017 for the territory of Greater China. Jilin MaiFu serves as MediFood's strategic partner for distribution and potential co-development of condition-specific clinical nutrition products in the Chinese market.
- Index AB (Indevex)minorCollaboration started in 2017 with Indevex AB (Sweden) for the Swedish market, focused on distribution of condition-specific clinical nutrition products.
- Rubenza Pharma (Slovakia)minorFirst export market entry in 2015. Rubenza Pharma distributes MediDrink products in Slovakia, representing MediFood's initial international expansion.
- Sole-Mizo Zrt. (Bonafarm Holding)coreManufacturing contract signed in 2010 for production of MediDrink portfolio at the Csorna manufacturing site. Sole-Mizo, as part of the Bonafarm Holding, manufactures MediFood's products. This partnership has been continuously upgraded, including modernization of the Csorna facility between 2020-2022.
Scale indicators7 records
Recent moves11 records
Expansion highlights6 records
MediFood competitors and assessment
Company assessmentBroad incumbents
- Baxter International (Clinical Nutrition): Multinational healthcare company with a clinical nutrition business (formerly part of Baxalta) offering enteral and ONS products used in hospitals. Comparable in serving disease-related malnutrition patients, though with broader portfolio and deeper hospital relationships than MediFood.
- Nestlé Health Science: Global medical nutrition arm of Nestlé, providing condition-specific ONS and enteral products (Peptamen, Impact, Modulen, Isosource) with deep hospital penetration and clinical evidence base. Closely comparable in targeting disease-related malnutrition across oncology, GI, pulmonary and perioperative settings.
- Abbott Nutrition: Global clinical nutrition leader offering disease-specific and standard oral nutritional supplements (e.g., Ensure, Pulmocare, Nepro, Vital) sold through hospital and pharmacy channels. Directly comparable in ONS for oncology, COPD, renal, and elderly indications, but at much larger scale and broader portfolio than MediFood.
- Nutricia (Danone): Specialist medical nutrition business of Danone, offering condition-specific ONS (Fortisip, Calogen, Renilon, Respifor) across oncology, COPD, renal, and gastrointestinal indications. Strong European distribution and KOL network make it the most direct large-scale competitor to MediDrink's condition-specific positioning.
- B. Braun Melsungen: Global medical device and nutrition company offering clinical nutrition products (Nutricomp, Fresenius Kabi-style ONS) sold primarily through European hospital channels. Comparable in targeting disease-related malnutrition and perioperative nutrition via condition-specific formulations.
- Fresenius Kabi: Major clinical nutrition player offering condition-specific ONS (Supportan, Fresubin, Diben) widely used in European hospitals for oncology, surgical, and elderly malnutrition. Comparable in product format and prescription-driven distribution, with much larger scale and tender presence than MediFood.
- Mead Johnson (Reckitt): Pediatric and medical nutrition brand under Reckitt offering condition-specific pediatric nutrition products. Comparable in serving disease-related malnutrition in pediatric patients (overlap with MediDrink Kids) and in clinical-nutrition sales model.
Regional players
- Hero Nutritionals: European nutrition company with medical and clinical nutrition offerings, including ONS and condition-specific supplements, distributed through pharmacy and hospital channels in select European markets. Comparable in product format (liquid ONS) and disease-targeting approach, though with broader consumer-nutrition portfolio.
Emerging players
- Victus (Laboratoires Grand Fontaine): European specialist in disease-specific ONS and enteral nutrition sold across multiple European countries. Comparable to MediFood in offering condition-tailored clinical nutrition beverages and in targeting similar hospital/prescriber channels at a similar scale.
Direct peers
- Aymes: UK-based medical nutrition company specializing in oral nutritional supplements (e.g., Aymes Shake, Aymes Complete) for disease-related malnutrition, distributed through pharmacies and healthcare professionals. Closely comparable to MediFood in product format, target indications, and UK market presence via MediFood UK Ltd.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
MediFood social profiles
Digital presenceMediFood compliance and trust
Trust signalCompliance1 record
MediFood financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediFood leadership team
Management profileNumber of profiles
Profiles13 records
MediFood subsidiaries and ownership
Company hierarchySubsidiaries3 records
MediFood funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediFood M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediFood
What does MediFood do?
MediFood develops, manufactures, and distributes condition-specific oral nutritional supplements (Foods for Special Medical Purposes, FSMP) under the MediDrink brand for patients with disease-related malnutrition. The portfolio covers 9+ therapeutic areas including oncology, COPD, cystic fibrosis, inflammatory bowel disease, elderly malnutrition, surgical/perioperative care, diabetes, and pediatric indications, with each formulation tailored in macronutrient and micronutrient profile to the specific disease state. Products are 200ml ready-to-use liquid supplements developed at the company's R&D Centre in Szeged, Hungary, and manufactured under contract in Csorna, Hungary, then sold to healthcare professionals and via 16 international distribution and licensing partners across Europe, Asia, the Middle East, and Africa (and under the LaVieCal brand in Germany).
Is MediFood a public or private company?
MediFood is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MediFood founded?
MediFood was founded in 2008. It employs 11 to 50 people.
Where is MediFood based?
MediFood is headquartered in Fribourg, Switzerland, in the Europe region.
How does MediFood make money?
Two revenue lines are on record. MediDrink Product Sales are the primary driver. The others are licensing and Partnership.
Who are MediFood's main competitors?
Broad incumbents on record are Baxter International (Clinical Nutrition), Nestlé Health Science, Abbott Nutrition, Nutricia (Danone), B. Braun Melsungen, Fresenius Kabi and Mead Johnson (Reckitt). Hero Nutritionals is listed as a regional player. Victus (Laboratoires Grand Fontaine) is listed as an emerging player. Aymes is listed as a direct peer.
Does MediFood have an API?
No public API is recorded for MediFood.
What industry is MediFood in?
MediFood's product category is Clinical Nutrition (Medical Foods / Foods for Special Medical Purposes). Its primary akta.pro industry code is CRADAGAN, Medical Nutrition & Meal Replacement (RTD, Bars, Powders), with a secondary code of AFAFAFAJ, Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements). Its NAICS code is 325412 and its SIC code is 2834.